COMMUNIQUÉS West-GlobeNewswire

The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges
31/07/2025
- Expects to reduce 2024 net loss and increase carrying value of assets held for sale by approximately $2.2 million - - Expects to increase first quarter 2025 net income by approximately $0.5 million, resulting in a [...]
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
30/07/2025
IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, August 6, 2025, to report its [...]
SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC
30/07/2025
TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat [...]
Capilea Mexico Celebrates 11,550 Successful Hair Graft Patients, Highlighting Mexico as a Safe Premier Destination for Hair Transplants
30/07/2025
Tijuana, BC , July 30, 2025 (GLOBE NEWSWIRE) -- Capilea Mexico , a leader in international hair restoration with over 25 years of experience, announced today it has successfully treated more than 11,550 hair graft [...]
STERIS Raises Dividend to $0.63 per share
30/07/2025
DUBLIN, IRELAND, July 30, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.63 per share. This represents a $ [...]
VITAS® Healthcare Announces CEO Transition and Appointment of New Chief Executive Officer
30/07/2025
MIRAMAR, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- VITAS Healthcare, one of the nation’s leading providers of hospice and palliative care, and a subsidiary of Chemed Corporation (NYSE: CHE), today announced that Nicholas [...]
Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference
30/07/2025
CLEARWATER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold [...]
Legal Bodybuilding SARMS: Why More Pro Lifters in 2025 Trust CrazyBulk’s Safe Alternatives to Gain Muscle, Increase Strength and Cutting
30/07/2025
New York City, NY, July 30, 2025 (GLOBE NEWSWIRE) -- CrazyBulk is leading the 2025 muscle-building evolution with what many experts consider the best SARMs for cutting and bulking legally available - no injections, no [...]
Arvinas to Report Second Quarter 2025 Financial Results on August 6, 2025
30/07/2025
NEW HAVEN, Conn., July 30, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that [...]
WeightWatchers Schedules Second Quarter 2025 Earnings Conference Call
30/07/2025
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) will release its results for the second quarter 2025 ended June 30, 2025, before market open on [...]
Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025
30/07/2025
REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today [...]
Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025
30/07/2025
SOUTH SAN FRANCISCO, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for [...]
MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025
30/07/2025
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , announced today that its second quarter 2025 financial results will be released before market open on [...]
IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients
30/07/2025
iMDx first dd-PCR assay to combine relative and absolute measurements of dd-cfDNA into single combined score Data show significantly improved positive predictive value (PPV) for graft rejection, which potentially [...]
Codexis to Report Second Quarter 2025 Financial Results on August 13
30/07/2025
REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that [...]
Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025
30/07/2025
IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the company will host a conference call and webcast on Wednesday, August 6, 2025 at 4:30 p.m [...]
Merit Medical Reports Second Quarter 2025 Results and Updates Full-Year Guidance
30/07/2025
Highlights† Reported revenue of $382.5 million, up 13.2% Constant currency revenue* and constant currency revenue, organic* up 12.5% and up 6.7%, respectively GAAP operating margin of 12.3%, compared to 13.6% in prior [...]
Lytus Fintech Expands NexFi Platform with XRP Integration, Unlocking New Revenue Streams and Global Liquidity
30/07/2025
Dubai, UAE, July 30, 2025 (GLOBE NEWSWIRE) -- Lytus Fintech, a business unit of Lytus Technologies Holdings PTV Ltd. (OTCMKTS: LYTHF) today announced the launch of its integration and support of XRP with its flagship [...]
Dyadic International, Inc. Announces Proposed Public Offering of Common Stock
30/07/2025
JUPITER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision [...]

Pages